StockDiagnosis

AMGN Stock Analysis — Amgen Inc

AI-powered earnings and news diagnosis. Updated regularly.

Company Overview

Sector
HEALTHCARE
P/E Ratio
25.65
EPS
$14.37
Profit Margin
0.21

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.

No public analysis available yet for AMGN.

Get a fresh AI diagnosis of AMGN

Sign up free — 3 analyses per month included.

Analyze AMGN Now